ArticleiMetaOmics2026
Majorbio Cloud: An integrated platform for single-omics and integrated multi-omics analysis of microbiome and metabolome.
Article in iMetaOmics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Advances in sequencing and mass spectrometry have propelled life sciences into the multi-omics era. Metabolomics and microbiomics are widely applied across various research fields, yet massive data analysis faces challenges like limited tool functionality and high technical barriers. The Majorbio Cloud Platform addresses these pain points by establishing four integrated workflows: Untargeted metabolomics, targeted metabolomics, microbiomics, and microbiome-metabolome integrated analysis, enabling one-stop analysis from single-omics to multi-omics correlation. In a real gut microbiome-metabolome case study, the platform pinpointed core differential microbes and characteristic metabolites, and further annotated functional pathways underlying host phenotypic divergence, demonstrating its reliability for mining biological mechanisms. The platform caters to both novice and experienced researchers with dual-parameter modes (default/customizable), multi-user collaboration, standardized pipelines, advanced analytical tools, and one-click color customization. By simplifying complex analytical procedures and reducing reliance on specialized programming skills, it offers a standardized, reproducible solution for multi-omics data analysis in related fields.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.